QUEST

Cognitive decline is often detected too late for effective intervention. QUEST is developed as an early screening method. Non-invasive eyetracking will be combined with real-time biomarker analysis aims for timely, personalized interventions. Our goal is to improve outcomes and reduce healthcare burdens.

• Cognitive decline is a critical public health challenge. The global population aged 65+ is expected to double by 2050, increasing impact on healthcare systems.
• Biomarkers for early prediction and tracking of cognitive impairment are needed for preventive measures and targeted therapies.
• QUEST aims to identify persons with risk factors and candidates for personalized interventions using eye-movement patterns.

Co-development with University of Miami (USA) and Alabama University (USA). Currently in discovery and early stage proof of principle.